nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Carvedilol—HIF1A—lung cancer	0.0148	0.383	CrCbGaD
Methocarbamol—Felbamate—CYP2E1—lung cancer	0.00726	0.187	CrCbGaD
Methocarbamol—Carvedilol—VEGFA—lung cancer	0.00597	0.154	CrCbGaD
Methocarbamol—Hypersensitivity—Teniposide—lung cancer	0.00373	0.00388	CcSEcCtD
Methocarbamol—Nausea—Pemetrexed—lung cancer	0.00372	0.00387	CcSEcCtD
Methocarbamol—Nausea—Gefitinib—lung cancer	0.00369	0.00384	CcSEcCtD
Methocarbamol—Conjunctivitis—Cisplatin—lung cancer	0.00367	0.00381	CcSEcCtD
Methocarbamol—Shock—Erlotinib—lung cancer	0.00366	0.0038	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Doxorubicin—lung cancer	0.00365	0.00379	CcSEcCtD
Methocarbamol—Angioedema—Vinorelbine—lung cancer	0.0036	0.00374	CcSEcCtD
Methocarbamol—Pruritus—Teniposide—lung cancer	0.00359	0.00373	CcSEcCtD
Methocarbamol—Vertigo—Vinorelbine—lung cancer	0.00354	0.00368	CcSEcCtD
Methocarbamol—Leukopenia—Vinorelbine—lung cancer	0.00352	0.00367	CcSEcCtD
Methocarbamol—Flushing—Irinotecan—lung cancer	0.00346	0.0036	CcSEcCtD
Methocarbamol—Bradycardia—Cisplatin—lung cancer	0.00345	0.00359	CcSEcCtD
Methocarbamol—Jaundice—Etoposide—lung cancer	0.00337	0.0035	CcSEcCtD
Methocarbamol—Insomnia—Erlotinib—lung cancer	0.00336	0.0035	CcSEcCtD
Methocarbamol—Pain—Vinblastine—lung cancer	0.00331	0.00344	CcSEcCtD
Methocarbamol—Dyspepsia—Topotecan—lung cancer	0.00331	0.00344	CcSEcCtD
Methocarbamol—Conjunctivitis—Paclitaxel—lung cancer	0.00329	0.00343	CcSEcCtD
Methocarbamol—Dyspepsia—Erlotinib—lung cancer	0.00327	0.0034	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—lung cancer	0.00326	0.00339	CcSEcCtD
Methocarbamol—Vomiting—Teniposide—lung cancer	0.00322	0.00335	CcSEcCtD
Methocarbamol—Anaphylactic shock—Vinorelbine—lung cancer	0.00321	0.00334	CcSEcCtD
Methocarbamol—Pain—Topotecan—lung cancer	0.00321	0.00334	CcSEcCtD
Methocarbamol—Rash—Teniposide—lung cancer	0.0032	0.00332	CcSEcCtD
Methocarbamol—Dermatitis—Teniposide—lung cancer	0.00319	0.00332	CcSEcCtD
Methocarbamol—Feeling abnormal—Vinblastine—lung cancer	0.00319	0.00331	CcSEcCtD
Methocarbamol—Pain—Erlotinib—lung cancer	0.00318	0.00331	CcSEcCtD
Methocarbamol—Headache—Teniposide—lung cancer	0.00317	0.0033	CcSEcCtD
Methocarbamol—Flushing—Cisplatin—lung cancer	0.00314	0.00327	CcSEcCtD
Methocarbamol—Thrombophlebitis—Methotrexate—lung cancer	0.0031	0.00323	CcSEcCtD
Methocarbamol—Bradycardia—Paclitaxel—lung cancer	0.0031	0.00322	CcSEcCtD
Methocarbamol—Feeling abnormal—Topotecan—lung cancer	0.0031	0.00322	CcSEcCtD
Methocarbamol—Nausea—Teniposide—lung cancer	0.00301	0.00313	CcSEcCtD
Methocarbamol—Hypotension—Vinorelbine—lung cancer	0.003	0.00312	CcSEcCtD
Methocarbamol—Urticaria—Topotecan—lung cancer	0.00298	0.0031	CcSEcCtD
Methocarbamol—Body temperature increased—Topotecan—lung cancer	0.00297	0.00309	CcSEcCtD
Methocarbamol—Body temperature increased—Erlotinib—lung cancer	0.00294	0.00306	CcSEcCtD
Methocarbamol—Carvedilol—CYP2E1—lung cancer	0.00292	0.0754	CrCbGaD
Methocarbamol—Vertigo—Irinotecan—lung cancer	0.00292	0.00303	CcSEcCtD
Methocarbamol—Syncope—Irinotecan—lung cancer	0.00291	0.00303	CcSEcCtD
Methocarbamol—Leukopenia—Irinotecan—lung cancer	0.00291	0.00302	CcSEcCtD
Methocarbamol—Carvedilol—CYP1A1—lung cancer	0.00288	0.0744	CrCbGaD
Methocarbamol—Flushing—Etoposide—lung cancer	0.00288	0.003	CcSEcCtD
Methocarbamol—Loss of consciousness—Irinotecan—lung cancer	0.00285	0.00297	CcSEcCtD
Methocarbamol—Hypersensitivity—Vinblastine—lung cancer	0.00285	0.00296	CcSEcCtD
Methocarbamol—Leukopenia—Gemcitabine—lung cancer	0.00283	0.00295	CcSEcCtD
Methocarbamol—Flushing—Paclitaxel—lung cancer	0.00282	0.00294	CcSEcCtD
Methocarbamol—Jaundice—Docetaxel—lung cancer	0.0028	0.00291	CcSEcCtD
Methocarbamol—Conjunctivitis—Docetaxel—lung cancer	0.00279	0.0029	CcSEcCtD
Methocarbamol—Vision blurred—Cisplatin—lung cancer	0.00278	0.00289	CcSEcCtD
Methocarbamol—Hypersensitivity—Topotecan—lung cancer	0.00277	0.00288	CcSEcCtD
Methocarbamol—Pain—Vinorelbine—lung cancer	0.00275	0.00286	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—lung cancer	0.00269	0.0028	CcSEcCtD
Methocarbamol—Confusional state—Irinotecan—lung cancer	0.00267	0.00278	CcSEcCtD
Methocarbamol—Pruritus—Topotecan—lung cancer	0.00266	0.00276	CcSEcCtD
Methocarbamol—Anaphylactic shock—Irinotecan—lung cancer	0.00265	0.00276	CcSEcCtD
Methocarbamol—Feeling abnormal—Vinorelbine—lung cancer	0.00265	0.00275	CcSEcCtD
Methocarbamol—Dysgeusia—Etoposide—lung cancer	0.00264	0.00275	CcSEcCtD
Methocarbamol—Leukopenia—Cisplatin—lung cancer	0.00264	0.00275	CcSEcCtD
Methocarbamol—Pruritus—Erlotinib—lung cancer	0.00263	0.00274	CcSEcCtD
Methocarbamol—Shock—Irinotecan—lung cancer	0.00261	0.00271	CcSEcCtD
Methocarbamol—Dysgeusia—Paclitaxel—lung cancer	0.00259	0.0027	CcSEcCtD
Methocarbamol—Anaphylactic shock—Gemcitabine—lung cancer	0.00258	0.00269	CcSEcCtD
Methocarbamol—Dizziness—Vinblastine—lung cancer	0.00256	0.00266	CcSEcCtD
Methocarbamol—Convulsion—Cisplatin—lung cancer	0.00255	0.00266	CcSEcCtD
Methocarbamol—Urticaria—Vinorelbine—lung cancer	0.00255	0.00266	CcSEcCtD
Methocarbamol—Body temperature increased—Vinorelbine—lung cancer	0.00254	0.00264	CcSEcCtD
Methocarbamol—Vision blurred—Paclitaxel—lung cancer	0.0025	0.0026	CcSEcCtD
Methocarbamol—Dizziness—Topotecan—lung cancer	0.00248	0.00258	CcSEcCtD
Methocarbamol—Hypotension—Irinotecan—lung cancer	0.00248	0.00258	CcSEcCtD
Methocarbamol—Vomiting—Vinblastine—lung cancer	0.00246	0.00256	CcSEcCtD
Methocarbamol—Dizziness—Erlotinib—lung cancer	0.00246	0.00256	CcSEcCtD
Methocarbamol—Vertigo—Etoposide—lung cancer	0.00243	0.00252	CcSEcCtD
Methocarbamol—Headache—Vinblastine—lung cancer	0.00242	0.00252	CcSEcCtD
Methocarbamol—Angioedema—Paclitaxel—lung cancer	0.00242	0.00252	CcSEcCtD
Methocarbamol—Leukopenia—Etoposide—lung cancer	0.00242	0.00252	CcSEcCtD
Methocarbamol—Hypotension—Gemcitabine—lung cancer	0.00241	0.00251	CcSEcCtD
Methocarbamol—Anaphylactic shock—Cisplatin—lung cancer	0.00241	0.0025	CcSEcCtD
Methocarbamol—Insomnia—Irinotecan—lung cancer	0.0024	0.00249	CcSEcCtD
Methocarbamol—Flushing—Docetaxel—lung cancer	0.00239	0.00249	CcSEcCtD
Methocarbamol—Vomiting—Topotecan—lung cancer	0.00239	0.00248	CcSEcCtD
Methocarbamol—Vertigo—Paclitaxel—lung cancer	0.00238	0.00248	CcSEcCtD
Methocarbamol—Syncope—Paclitaxel—lung cancer	0.00237	0.00247	CcSEcCtD
Methocarbamol—Loss of consciousness—Etoposide—lung cancer	0.00237	0.00247	CcSEcCtD
Methocarbamol—Leukopenia—Paclitaxel—lung cancer	0.00237	0.00247	CcSEcCtD
Methocarbamol—Rash—Topotecan—lung cancer	0.00237	0.00246	CcSEcCtD
Methocarbamol—Hypersensitivity—Vinorelbine—lung cancer	0.00237	0.00246	CcSEcCtD
Methocarbamol—Dermatitis—Topotecan—lung cancer	0.00237	0.00246	CcSEcCtD
Methocarbamol—Vomiting—Erlotinib—lung cancer	0.00236	0.00246	CcSEcCtD
Methocarbamol—Somnolence—Irinotecan—lung cancer	0.00236	0.00245	CcSEcCtD
Methocarbamol—Headache—Topotecan—lung cancer	0.00235	0.00245	CcSEcCtD
Methocarbamol—Rash—Erlotinib—lung cancer	0.00234	0.00244	CcSEcCtD
Methocarbamol—Dermatitis—Erlotinib—lung cancer	0.00234	0.00244	CcSEcCtD
Methocarbamol—Convulsion—Etoposide—lung cancer	0.00234	0.00243	CcSEcCtD
Methocarbamol—Insomnia—Gemcitabine—lung cancer	0.00233	0.00243	CcSEcCtD
Methocarbamol—Dyspepsia—Irinotecan—lung cancer	0.00233	0.00243	CcSEcCtD
Methocarbamol—Headache—Erlotinib—lung cancer	0.00233	0.00242	CcSEcCtD
Methocarbamol—Loss of consciousness—Paclitaxel—lung cancer	0.00233	0.00242	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—lung cancer	0.00233	0.00242	CcSEcCtD
Methocarbamol—Nausea—Vinblastine—lung cancer	0.0023	0.00239	CcSEcCtD
Methocarbamol—Somnolence—Gemcitabine—lung cancer	0.00229	0.00239	CcSEcCtD
Methocarbamol—Convulsion—Paclitaxel—lung cancer	0.00229	0.00239	CcSEcCtD
Methocarbamol—Pruritus—Vinorelbine—lung cancer	0.00227	0.00236	CcSEcCtD
Methocarbamol—Pain—Irinotecan—lung cancer	0.00227	0.00236	CcSEcCtD
Methocarbamol—Hypotension—Cisplatin—lung cancer	0.00225	0.00234	CcSEcCtD
Methocarbamol—Nausea—Topotecan—lung cancer	0.00223	0.00232	CcSEcCtD
Methocarbamol—Confusional state—Etoposide—lung cancer	0.00222	0.00231	CcSEcCtD
Methocarbamol—Pain—Gemcitabine—lung cancer	0.00221	0.0023	CcSEcCtD
Methocarbamol—Nausea—Erlotinib—lung cancer	0.00221	0.0023	CcSEcCtD
Methocarbamol—Anaphylactic shock—Etoposide—lung cancer	0.0022	0.00229	CcSEcCtD
Methocarbamol—Dysgeusia—Docetaxel—lung cancer	0.0022	0.00229	CcSEcCtD
Methocarbamol—Propranolol—CYP1A1—lung cancer	0.00219	0.0566	CrCbGaD
Methocarbamol—Feeling abnormal—Irinotecan—lung cancer	0.00218	0.00227	CcSEcCtD
Methocarbamol—Confusional state—Paclitaxel—lung cancer	0.00218	0.00227	CcSEcCtD
Methocarbamol—Anaphylactic shock—Paclitaxel—lung cancer	0.00216	0.00225	CcSEcCtD
Methocarbamol—Feeling abnormal—Gemcitabine—lung cancer	0.00213	0.00221	CcSEcCtD
Methocarbamol—Shock—Paclitaxel—lung cancer	0.00213	0.00221	CcSEcCtD
Methocarbamol—Dizziness—Vinorelbine—lung cancer	0.00212	0.00221	CcSEcCtD
Methocarbamol—Body temperature increased—Irinotecan—lung cancer	0.00209	0.00218	CcSEcCtD
Methocarbamol—Drowsiness—Methotrexate—lung cancer	0.00207	0.00215	CcSEcCtD
Methocarbamol—Hypotension—Etoposide—lung cancer	0.00206	0.00214	CcSEcCtD
Methocarbamol—Pain—Cisplatin—lung cancer	0.00206	0.00214	CcSEcCtD
Methocarbamol—Vomiting—Vinorelbine—lung cancer	0.00204	0.00213	CcSEcCtD
Methocarbamol—Body temperature increased—Gemcitabine—lung cancer	0.00204	0.00212	CcSEcCtD
Methocarbamol—Rash—Vinorelbine—lung cancer	0.00203	0.00211	CcSEcCtD
Methocarbamol—Dermatitis—Vinorelbine—lung cancer	0.00202	0.00211	CcSEcCtD
Methocarbamol—Hypotension—Paclitaxel—lung cancer	0.00202	0.0021	CcSEcCtD
Methocarbamol—Headache—Vinorelbine—lung cancer	0.00201	0.00209	CcSEcCtD
Methocarbamol—Syncope—Docetaxel—lung cancer	0.00201	0.00209	CcSEcCtD
Methocarbamol—Conjunctivitis—Methotrexate—lung cancer	0.00201	0.00209	CcSEcCtD
Methocarbamol—Leukopenia—Docetaxel—lung cancer	0.00201	0.00209	CcSEcCtD
Methocarbamol—Feeling abnormal—Cisplatin—lung cancer	0.00198	0.00206	CcSEcCtD
Methocarbamol—Loss of consciousness—Docetaxel—lung cancer	0.00197	0.00205	CcSEcCtD
Methocarbamol—Somnolence—Etoposide—lung cancer	0.00196	0.00204	CcSEcCtD
Methocarbamol—Insomnia—Paclitaxel—lung cancer	0.00195	0.00203	CcSEcCtD
Methocarbamol—Hypersensitivity—Irinotecan—lung cancer	0.00195	0.00203	CcSEcCtD
Methocarbamol—Convulsion—Docetaxel—lung cancer	0.00194	0.00202	CcSEcCtD
Methocarbamol—Somnolence—Paclitaxel—lung cancer	0.00192	0.002	CcSEcCtD
Methocarbamol—Nausea—Vinorelbine—lung cancer	0.00191	0.00199	CcSEcCtD
Methocarbamol—Dyspepsia—Paclitaxel—lung cancer	0.0019	0.00198	CcSEcCtD
Methocarbamol—Body temperature increased—Cisplatin—lung cancer	0.0019	0.00198	CcSEcCtD
Methocarbamol—Pain—Etoposide—lung cancer	0.00188	0.00196	CcSEcCtD
Methocarbamol—Pain—Paclitaxel—lung cancer	0.00185	0.00192	CcSEcCtD
Methocarbamol—Confusional state—Docetaxel—lung cancer	0.00185	0.00192	CcSEcCtD
Methocarbamol—Anaphylactic shock—Docetaxel—lung cancer	0.00183	0.00191	CcSEcCtD
Methocarbamol—Pruritus—Gemcitabine—lung cancer	0.00183	0.0019	CcSEcCtD
Methocarbamol—Feeling abnormal—Etoposide—lung cancer	0.00182	0.00189	CcSEcCtD
Methocarbamol—Shock—Docetaxel—lung cancer	0.0018	0.00187	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—lung cancer	0.00179	0.00186	CcSEcCtD
Methocarbamol—Feeling abnormal—Paclitaxel—lung cancer	0.00178	0.00185	CcSEcCtD
Methocarbamol—Hypersensitivity—Cisplatin—lung cancer	0.00177	0.00184	CcSEcCtD
Methocarbamol—Dizziness—Irinotecan—lung cancer	0.00175	0.00182	CcSEcCtD
Methocarbamol—Urticaria—Etoposide—lung cancer	0.00175	0.00182	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—lung cancer	0.00175	0.00182	CcSEcCtD
Methocarbamol—Body temperature increased—Etoposide—lung cancer	0.00174	0.00181	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—lung cancer	0.00174	0.00181	CcSEcCtD
Methocarbamol—Urticaria—Paclitaxel—lung cancer	0.00172	0.00179	CcSEcCtD
Methocarbamol—Hypotension—Docetaxel—lung cancer	0.00171	0.00178	CcSEcCtD
Methocarbamol—Body temperature increased—Paclitaxel—lung cancer	0.00171	0.00178	CcSEcCtD
Methocarbamol—Vomiting—Irinotecan—lung cancer	0.00168	0.00175	CcSEcCtD
Methocarbamol—Rash—Irinotecan—lung cancer	0.00167	0.00174	CcSEcCtD
Methocarbamol—Dermatitis—Irinotecan—lung cancer	0.00167	0.00174	CcSEcCtD
Methocarbamol—Headache—Irinotecan—lung cancer	0.00166	0.00173	CcSEcCtD
Methocarbamol—Insomnia—Docetaxel—lung cancer	0.00166	0.00172	CcSEcCtD
Methocarbamol—Vomiting—Gemcitabine—lung cancer	0.00164	0.00171	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—lung cancer	0.00164	0.0017	CcSEcCtD
Methocarbamol—Somnolence—Docetaxel—lung cancer	0.00163	0.00169	CcSEcCtD
Methocarbamol—Rash—Gemcitabine—lung cancer	0.00163	0.00169	CcSEcCtD
Methocarbamol—Dermatitis—Gemcitabine—lung cancer	0.00163	0.00169	CcSEcCtD
Methocarbamol—Hypersensitivity—Etoposide—lung cancer	0.00162	0.00169	CcSEcCtD
Methocarbamol—Headache—Gemcitabine—lung cancer	0.00162	0.00168	CcSEcCtD
Methocarbamol—Dyspepsia—Docetaxel—lung cancer	0.00161	0.00168	CcSEcCtD
Methocarbamol—Hypersensitivity—Paclitaxel—lung cancer	0.00159	0.00166	CcSEcCtD
Methocarbamol—Dysgeusia—Methotrexate—lung cancer	0.00158	0.00165	CcSEcCtD
Methocarbamol—Nausea—Irinotecan—lung cancer	0.00157	0.00164	CcSEcCtD
Methocarbamol—Pain—Docetaxel—lung cancer	0.00157	0.00163	CcSEcCtD
Methocarbamol—Pruritus—Etoposide—lung cancer	0.00156	0.00162	CcSEcCtD
Methocarbamol—Nausea—Gemcitabine—lung cancer	0.00153	0.0016	CcSEcCtD
Methocarbamol—Carvedilol—ABCB1—lung cancer	0.00153	0.0395	CrCbGaD
Methocarbamol—Vomiting—Cisplatin—lung cancer	0.00153	0.00159	CcSEcCtD
Methocarbamol—Pruritus—Paclitaxel—lung cancer	0.00153	0.00159	CcSEcCtD
Methocarbamol—Vision blurred—Methotrexate—lung cancer	0.00152	0.00159	CcSEcCtD
Methocarbamol—Rash—Cisplatin—lung cancer	0.00152	0.00158	CcSEcCtD
Methocarbamol—Dermatitis—Cisplatin—lung cancer	0.00152	0.00158	CcSEcCtD
Methocarbamol—Feeling abnormal—Docetaxel—lung cancer	0.00151	0.00157	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—lung cancer	0.00149	0.00155	CcSEcCtD
Methocarbamol—Dizziness—Etoposide—lung cancer	0.00146	0.00152	CcSEcCtD
Methocarbamol—Vertigo—Methotrexate—lung cancer	0.00145	0.00151	CcSEcCtD
Methocarbamol—Body temperature increased—Docetaxel—lung cancer	0.00145	0.00151	CcSEcCtD
Methocarbamol—Leukopenia—Methotrexate—lung cancer	0.00145	0.00151	CcSEcCtD
Methocarbamol—Dizziness—Paclitaxel—lung cancer	0.00143	0.00149	CcSEcCtD
Methocarbamol—Nausea—Cisplatin—lung cancer	0.00143	0.00149	CcSEcCtD
Methocarbamol—Convulsion—Methotrexate—lung cancer	0.0014	0.00146	CcSEcCtD
Methocarbamol—Vomiting—Etoposide—lung cancer	0.0014	0.00146	CcSEcCtD
Methocarbamol—Rash—Etoposide—lung cancer	0.00139	0.00145	CcSEcCtD
Methocarbamol—Dermatitis—Etoposide—lung cancer	0.00139	0.00144	CcSEcCtD
Methocarbamol—Headache—Etoposide—lung cancer	0.00138	0.00144	CcSEcCtD
Methocarbamol—Vomiting—Paclitaxel—lung cancer	0.00137	0.00143	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—lung cancer	0.00137	0.00143	CcSEcCtD
Methocarbamol—Rash—Paclitaxel—lung cancer	0.00136	0.00142	CcSEcCtD
Methocarbamol—Dermatitis—Paclitaxel—lung cancer	0.00136	0.00142	CcSEcCtD
Methocarbamol—Headache—Paclitaxel—lung cancer	0.00135	0.00141	CcSEcCtD
Methocarbamol—Hypersensitivity—Docetaxel—lung cancer	0.00135	0.0014	CcSEcCtD
Methocarbamol—Confusional state—Methotrexate—lung cancer	0.00133	0.00138	CcSEcCtD
Methocarbamol—Anaphylactic shock—Methotrexate—lung cancer	0.00132	0.00137	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—lung cancer	0.00132	0.00137	CcSEcCtD
Methocarbamol—Nausea—Etoposide—lung cancer	0.00131	0.00136	CcSEcCtD
Methocarbamol—Pruritus—Docetaxel—lung cancer	0.0013	0.00135	CcSEcCtD
Methocarbamol—Nausea—Paclitaxel—lung cancer	0.00128	0.00134	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—lung cancer	0.00126	0.00131	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—lung cancer	0.00126	0.00131	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—lung cancer	0.00125	0.0013	CcSEcCtD
Methocarbamol—Hypotension—Methotrexate—lung cancer	0.00123	0.00128	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—lung cancer	0.00123	0.00128	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—lung cancer	0.00121	0.00126	CcSEcCtD
Methocarbamol—Dizziness—Docetaxel—lung cancer	0.00121	0.00126	CcSEcCtD
Methocarbamol—Insomnia—Methotrexate—lung cancer	0.00119	0.00124	CcSEcCtD
Methocarbamol—Somnolence—Methotrexate—lung cancer	0.00117	0.00122	CcSEcCtD
Methocarbamol—Vomiting—Docetaxel—lung cancer	0.00116	0.00121	CcSEcCtD
Methocarbamol—Propranolol—ABCB1—lung cancer	0.00116	0.0301	CrCbGaD
Methocarbamol—Dyspepsia—Methotrexate—lung cancer	0.00116	0.00121	CcSEcCtD
Methocarbamol—Rash—Docetaxel—lung cancer	0.00116	0.0012	CcSEcCtD
Methocarbamol—Dermatitis—Docetaxel—lung cancer	0.00115	0.0012	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—lung cancer	0.00115	0.0012	CcSEcCtD
Methocarbamol—Headache—Docetaxel—lung cancer	0.00115	0.00119	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—lung cancer	0.00114	0.00119	CcSEcCtD
Methocarbamol—Pain—Methotrexate—lung cancer	0.00113	0.00117	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—lung cancer	0.00112	0.00117	CcSEcCtD
Methocarbamol—Nausea—Docetaxel—lung cancer	0.00109	0.00113	CcSEcCtD
Methocarbamol—Feeling abnormal—Methotrexate—lung cancer	0.00109	0.00113	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—lung cancer	0.00107	0.00111	CcSEcCtD
Methocarbamol—Urticaria—Methotrexate—lung cancer	0.00105	0.00109	CcSEcCtD
Methocarbamol—Body temperature increased—Methotrexate—lung cancer	0.00104	0.00109	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—lung cancer	0.00103	0.00108	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—lung cancer	0.00102	0.00106	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—lung cancer	0.00101	0.00105	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—lung cancer	0.000978	0.00102	CcSEcCtD
Methocarbamol—Hypersensitivity—Methotrexate—lung cancer	0.000973	0.00101	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—lung cancer	0.000942	0.00098	CcSEcCtD
Methocarbamol—Pruritus—Methotrexate—lung cancer	0.000934	0.000972	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—lung cancer	0.000908	0.000945	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—lung cancer	0.000904	0.00094	CcSEcCtD
Methocarbamol—Dizziness—Methotrexate—lung cancer	0.000873	0.000908	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—lung cancer	0.000842	0.000876	CcSEcCtD
Methocarbamol—Vomiting—Methotrexate—lung cancer	0.000839	0.000873	CcSEcCtD
Methocarbamol—Rash—Methotrexate—lung cancer	0.000832	0.000866	CcSEcCtD
Methocarbamol—Dermatitis—Methotrexate—lung cancer	0.000832	0.000865	CcSEcCtD
Methocarbamol—Headache—Methotrexate—lung cancer	0.000827	0.00086	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—lung cancer	0.000809	0.000841	CcSEcCtD
Methocarbamol—Nausea—Methotrexate—lung cancer	0.000784	0.000816	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—lung cancer	0.000756	0.000786	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—lung cancer	0.000727	0.000756	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—lung cancer	0.000721	0.00075	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—lung cancer	0.00072	0.000749	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—lung cancer	0.000716	0.000745	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—lung cancer	0.000679	0.000706	CcSEcCtD
